ATE105837T1 - Arylsulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen. - Google Patents

Arylsulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen.

Info

Publication number: ATE105837T1
Authority: AT; Austria
Prior art keywords: alkyl; pharmaceutical compositions; formula; ring; group
Prior art date: 1989-02-03

Application number

AT90902647T

Other languages

English (en)

Inventor

David Robert Brittain

Michael Thomas Cox

Original Assignee

Ici Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-03

Filing date

1990-02-01

Publication date

1994-06-15

1989-02-03 Priority claimed from GB898902407A external-priority patent/GB8902407D0/en

1989-02-03 Priority claimed from GB898902410A external-priority patent/GB8902410D0/en

1990-02-01 Application filed by Ici Plc filed Critical Ici Plc

1994-06-15 Application granted granted Critical

1994-06-15 Publication of ATE105837T1 publication Critical patent/ATE105837T1/de

Links

238000000034 method Methods 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 2
208000002249 Diabetes Complications Diseases 0.000 abstract 1
206010012655 Diabetic complications Diseases 0.000 abstract 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
239000005977 Ethylene Substances 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
125000001589 carboacyl group Chemical group 0.000 abstract 1
125000001153 fluoro group Chemical group F* 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000005647 linker group Chemical group 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
125000001174 sulfone group Chemical group 0.000 abstract 1
125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Emergency Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Endocrinology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)
Indole Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Quinoline Compounds (AREA)
Furan Compounds (AREA)
Pyrane Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT90902647T 1989-02-03 1990-02-01 Arylsulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen. ATE105837T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB898902407A GB8902407D0 (en)	1989-02-03	1989-02-03	Heterocyclic compounds
GB898902410A GB8902410D0 (en)	1989-02-03	1989-02-03	Bicyclic compounds

Publications (1)

Publication Number	Publication Date
ATE105837T1 true ATE105837T1 (de)	1994-06-15

Family

ID=26294911

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90902647T ATE105837T1 (de)	1989-02-03	1990-02-01	Arylsulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen.

Country Status (12)

Country	Link
US (1)	US5185452A (de)
EP (1)	EP0409949B1 (de)
JP (1)	JPH04504250A (de)
AT (1)	ATE105837T1 (de)
AU (1)	AU631602B2 (de)
CA (1)	CA2025768A1 (de)
DE (1)	DE69008956D1 (de)
GR (1)	GR1000378B (de)
IL (1)	IL93178A0 (de)
NZ (1)	NZ232349A (de)
PT (1)	PT93052A (de)
WO (1)	WO1990008763A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH11106381A (ja) *	1997-09-30	1999-04-20	Ss Pharmaceut Co Ltd	クロメン誘導体及びその塩並びにこれを含有する医薬
US7620437B2 (en) *	2005-06-03	2009-11-17	Abbott Diabetes Care Inc.	Method and apparatus for providing rechargeable power in data monitoring and management systems
JP2011043839A (ja) *	2010-09-29	2011-03-03	Panasonic Corp	レジスト材料及びそれを用いたパターン形成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1229653A (de) *	1968-03-14	1971-04-28
US3882247A (en) *	1972-04-21	1975-05-06	Du Pont	Fungicidal nitro organic sulfur compounds
US4053633A (en) *	1976-06-24	1977-10-11	The Dow Chemical Company	Aryl dibromonitromethyl sulfones
US4670470A (en) *	1979-08-15	1987-06-02	Merck & Co., Inc.	Allylsulfoxide enzyme inhibitors
US4309554A (en) *	1980-04-28	1982-01-05	The Dow Chemical Company	3-(2-Thiophenesulfonyl)-2-halopropanenitriles
JPS5740478A (en) *	1980-08-22	1982-03-06	Ono Pharmaceut Co Ltd	Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
DE3326635A1 (de) *	1983-07-23	1985-01-31	Bayer Ag, 5090 Leverkusen	Verfahren zur herstellung von monomethylsubstituierten methylen-verbindungen
GB8718619D0 (en) *	1987-08-06	1987-09-09	Ici Plc	Pharmaceutical compositions
GB8810203D0 (en) *	1988-04-29	1988-06-02	Ici Plc	Heterocyclic compounds

1990
- 1990-01-25 IL IL93178A patent/IL93178A0/xx unknown
- 1990-02-01 WO PCT/GB1990/000164 patent/WO1990008763A1/en not_active Ceased
- 1990-02-01 AU AU50308/90A patent/AU631602B2/en not_active Ceased
- 1990-02-01 AT AT90902647T patent/ATE105837T1/de not_active IP Right Cessation
- 1990-02-01 DE DE69008956T patent/DE69008956D1/de not_active Expired - Lifetime
- 1990-02-01 CA CA002025768A patent/CA2025768A1/en not_active Abandoned
- 1990-02-01 JP JP2502694A patent/JPH04504250A/ja active Pending
- 1990-02-01 EP EP90902647A patent/EP0409949B1/de not_active Expired - Lifetime
- 1990-02-02 PT PT93052A patent/PT93052A/pt not_active Application Discontinuation
- 1990-02-02 NZ NZ232349A patent/NZ232349A/en unknown
- 1990-02-05 US US07/474,940 patent/US5185452A/en not_active Expired - Fee Related
- 1990-02-05 GR GR900100068A patent/GR1000378B/el unknown

Also Published As

Publication number	Publication date
GR1000378B (el)	1992-06-30
PT93052A (pt)	1990-08-31
JPH04504250A (ja)	1992-07-30
EP0409949B1 (de)	1994-05-18
US5185452A (en)	1993-02-09
GR900100068A (en)	1991-06-28
NZ232349A (en)	1992-06-25
IL93178A0 (en)	1990-11-05
AU5030890A (en)	1990-08-24
AU631602B2 (en)	1992-12-03
WO1990008763A1 (en)	1990-08-09
CA2025768A1 (en)	1990-08-04
DE69008956D1 (de)	1994-06-23
EP0409949A1 (de)	1991-01-30

Legal Events

Date	Code	Title	Description
1994-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69021176D1 (de)	1995-08-31	Polypeptid und Verfahren zu dessen Herstellung.
DE68901153D1 (de)	1992-05-14	Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
HUT56092A (en)	1991-07-29	Process for producing 2-amino-pyrimidine-4-carboxamide derivatives and pharmaceutical compositions containing them
HUT51250A (en)	1990-04-28	Process for production of derivatives of sulfhonamid and medical compositions containing them
GR900100406A (en)	1991-11-15	Preparation process for a pharmaceutical treatment composition
ATE6776T1 (de)	1984-04-15	Nonapeptide und decapeptide, agonisten des ''lh- rh''-faktors, welche heterocyclische aminosaeurereste enthalten, verfahren zu deren herstellung, deren pharmazeutische zusammensetzungen und deren pharmazeutische verwendung.
ATE193531T1 (de)	2000-06-15	Phenyl-carboxamide-isoxazole-derivate und salze, verfahren zu ihrer herstellung ihre anwendung als arzneimittel und pharmazeutische zusammensetzungen die sie enthalten
SE8802008L (sv)	1988-05-30	Mellanprodukt foer framstaellning av fluorometyltiooxacefalosporiner
ATE105837T1 (de)	1994-06-15	Arylsulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
ATE107298T1 (de)	1994-07-15	3-aminochroman-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE116647T1 (de)	1995-01-15	Thiophenderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE121405T1 (de)	1995-05-15	Oxazolopyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE100797T1 (de)	1994-02-15	Heterozyklische sulphonylnitromethane, verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
SG43191G (en)	1991-08-23	Isoxazole derivatives, process for their preparation and pharmaceutical compositions containing them
ATE19879T1 (de)	1986-06-15	Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE101610T1 (de)	1994-03-15	Indol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
GR3033175T3 (en)	2000-08-31	Trifluoromethylsulfonylphenyl or trifluoromethylsulfinylphenyl group containing 2-cyano-3-hydroxy-propenamide derivatives, process for their preparation, their use as medicaments and pharmaceutical compositions containing them
ATE124942T1 (de)	1995-07-15	2-aminopyrimidin-4-carboxamidderivate, deren herstellung und deren verwendung als heilmittel.
TW349945B (en)	1999-01-11	Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic
ATE117682T1 (de)	1995-02-15	Substituierte benzothiazolinone, ihre herstellung und sie enthaltende pharmazeutische zusammenstellungen.
ATE9091T1 (de)	1984-09-15	Substituierte phenoxyacetate cyclischer amine, verfahren zu ihrer herstellung, ihre anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen.
ATE130309T1 (de)	1995-12-15	14alpha,16alpha-ethano- und 14alpha,16alpha- ethenoestratriene.
ATE139780T1 (de)	1996-07-15	Amidderivate von 1-amino-octahydropyrido(2,1- c>(1,4>oxazin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen